↓ Skip to main content

Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb

Overview of attention for article published in BMC Medical Genomics, January 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb
Published in
BMC Medical Genomics, January 2015
DOI 10.1186/s12920-015-0076-2
Pubmed ID
Authors

Elisabeth Castellanos, Isabel Bielsa, Cristina Carrato, Imma Rosas, Ares Solanes, Cristina Hostalot, Emilio Amilibia, José Prades, Francesc Roca-Ribas, Conxi Lázaro, Ignacio Blanco, Eduard Serra, on behalf of the NF2 Multidisciplinary Clinics HUGTiP-ICO-IMPPC

Abstract

A clinical overlap exists between mosaic Neurofibromatosis Type 2 and sporadic Schwannomatosis conditions. In these cases a molecular analysis of tumors is recommended for a proper genetic diagnostics. This analysis is challenged by the fact that schwannomas in both conditions bear a somatic double inactivation of the NF2 gene. However, SMARCB1-associated schwannomas follow a four-hit, three-step model, in which both alleles of SMARCB1 and NF2 genes are inactivated in the tumor, with one of the steps being always the loss of a big part of chromosome 22 involving both loci.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Unknown 45 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 14 30%
Researcher 6 13%
Student > Postgraduate 5 11%
Student > Ph. D. Student 3 7%
Student > Master 3 7%
Other 7 15%
Unknown 8 17%
Readers by discipline Count As %
Medicine and Dentistry 16 35%
Unspecified 12 26%
Biochemistry, Genetics and Molecular Biology 4 9%
Agricultural and Biological Sciences 3 7%
Veterinary Science and Veterinary Medicine 1 2%
Other 2 4%
Unknown 8 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 March 2017.
All research outputs
#14,156,005
of 22,793,427 outputs
Outputs from BMC Medical Genomics
#557
of 1,223 outputs
Outputs of similar age
#185,873
of 352,060 outputs
Outputs of similar age from BMC Medical Genomics
#20
of 35 outputs
Altmetric has tracked 22,793,427 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,223 research outputs from this source. They receive a mean Attention Score of 4.7. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,060 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.